ARTICLE | Company News
Retrophin rises on $245M voucher sale to Sanofi
May 28, 2015 1:47 AM UTC
Retrophin Inc. (NASDAQ:RTRX) jumped $3.18 (12%) to $30.05 on Wednesday after selling a Priority Review voucher to Sanofi (Euronext:SAN; NYSE:SNY) for $245 million. Sanofi spokesperson Mary Kathryn Steel declined to disclose what the company will do with the voucher. ...